Qube Research & Technologies LTD Bristol Myers Squibb CO Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4,690,379 shares of BMY stock, worth $232 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

4,690,379

Previous 119,600 3821.72%

Holding current value

$232 Million

Previous $6.49 Million 2903.72%

% of portfolio

0.31%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $60.3 Million - $79.4 Million	1,498,953 Added 46.97%	4,690,379 $195 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $168 Million - $191 Million	-3,503,168 Reduced 52.33%	3,191,426 $173 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $156 Million - $186 Million	3,208,186 Added 92.02%	6,694,594 $343 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $59.9 Million - $67 Million	1,035,243 Added 42.23%	3,486,408 $202 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $127 Million - $141 Million	1,986,534 Added 427.55%	2,451,165 $157 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $64.8 Million - $73.5 Million	-986,386 Reduced 67.98%	464,631 $32.2 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $99.4 Million - $118 Million	1,451,017 New	1,451,017 $104 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $74.2 Million - $81.7 Million	1,021,867 Added 2107.29%	1,070,359 $82.4 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $2.98 Million - $3.57 Million	48,492 New	48,492 $3.54 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $12.6 Million - $14.7 Million	-235,469 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $13.9 Million - $16.3 Million	235,469 New	235,469 $13.9 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $20.1 Million - $21.9 Million	-325,357 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $17.5 Million - $19.7 Million	294,817 Added 965.35%	325,357 $20.5 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.43 Million - $1.62 Million	24,717 Added 424.47%	30,540 $1.89 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $92,232 - $102,205	1,606 Added 38.08%	5,823 $351,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $231,175 - $270,267	4,217 New	4,217 $248,000
Q2 2019 Aug 02, 2019	SELL	$44.62 - $49.34 $2.71 Million - $2.99 Million	-60,669 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $2.74 Million - $3.26 Million	60,669 New	60,669 $2.9 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.03 Million - $1.34 Million	-21,221 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $1.05 Million - $1.19 Million	19,108 Added 904.31%	21,221 $1.32 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $83,222 - $103,728	-1,647 Reduced 43.8%	2,113 $117,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $225,299 - $259,364	3,760 New	3,760 $237,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $105B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Bristol Myers Squibb CO Transaction History